RTS

(redirected from CREBBP)
Also found in: Dictionary, Medical, Acronyms, Encyclopedia.
Related to CREBBP: EP300

Russian Trading System (RTS)

An electronic system in Russia, like the Nasdaq system on which the majority of Russian equities trading is conducted.

RTS

An electronic stock market in Russia. It was established in 1995 and was modeled on NASDAQ. Its securities experienced an extraordinary amount of growth in the early 2000s. See also: RTS Index.
References in periodicals archive ?
(a) Relative mRNA levels of histone acetyltransferases (P300, CREBBP) in [CD4.sup.+] T lymphocytes from patients with LADA (n = 28) and controls (n = 28), as measured by real-time PCR.
(a) Relative mRNA levels of histone acetyltransferase (CREBBP) in [CD4.sup.+] T lymphocytes from patients with LADA, LADA patients with complications (LADAc, n = 17) versus LADA patients without complications (LADAnc, n = 11), * P < 0.05.
Proteins in the gel were transferred onto polyvinylidene difluoride (PVDF) membrane (pore size, 0.45 [micro]m; Millipore, Bedford, MA, USA) by electro-blotting (Matsuda et al., 2004) and then treated with rabbit polyclonal antibody against the DNA-binding domain of mouse JUN (D, 0.04 [micro]g/ml; Santa Cruz Biotechnology, Santa Cruz, CA, USA), the C-terminus of human ETS2 (C-20, 0.04 [micro]g/ml; Santa Cruz Biotechnology), the N-terminus of human CDX2 (ab22586, 0.04 [micro]g/ml; Abcam, Cambridge, UK), the N-terminus of human OCT4 (N-19, 0.04 [micro]g/ml; Santa Cruz Biotechnology), or the C-terminus of human CREBBP (C-1, 0.04 [micro]g/ml; Santa Cruz Biotechnology).
(13, 14) A South Korean study by Jung et al (14) reported that TNFAIP3 was the most frequently mutated gene in ocular MZL followed by TBL1XR1 and CREBBP, and MYD88 mutation was identified in only 4% of patients.
elegans) (EGLN3); E1A binding protein p300 (EP300); and CREB binding protein (CREBBP), whereas miR-200b, miR-200c, and miR-429 target VHL; transcription elongation factor B (SIII), polypeptide 1 (15 kDa, elongin C) (TCEB1); EGLN1/3; EP300; and CREBBP.
B01 PTEN loss; 0 RB1 splice site 607+2T>A (19) TP53 Y220S (26) CREBBP K1086* (18) B02 PTEN R14fs*10 (24) TP53 VI 73fs*7 (33) TNERSEl 4 loss; 0 B03 PIK3CA H1047R (4) TP53 K320* (5) B04 MCL1 amplification; 7 ARID1A R1722* (4) NFKBIA amplification; 6 PTPN11 S502L (2) B05 PIK3R1 Y580fs*19 (42) CCND2 amplification; 24 CDKN2A loss; 0 FCF23 amplification; 24 B06 FANCA CI 410fs*6 (12) MYC amplification; 8 B07 CDK4 amplification;!